Mariposa Technologies Inc joins American Heart Association Innovators’ Network
Mariposa Technologies Inc, the designer of technology and tools to make life…
PALO ALTO, Calif.–(BUSINESS WIRE)–Medable Inc. today announced $91 million in new funding to accelerate the life sciences industry’s shift to digital and decentralized clinical trials. The Series C funding round was led by Sapphire Ventures, with follow-on investment from existing investors GSR Ventures, PPD, Inc. (Nasdaq:PPD) and Streamlined Ventures. The funding brings Medable’s total capital raised to more than $136 million. For more, click here.
Mariposa Technologies Inc, the designer of technology and tools to make life…
Time is running out to submit to have your Science at AHA…
In honor of National Women’s Health Month, the American Heart Association’s Center for…